Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver regeneration during immunosuppression.

J P Coughlin, W G Austen, P K Donahoe

    Journal of Pediatric Surgery
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

    Current molecular medicine·2016
    Same author

    An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

    Technology (Elmsford, N.Y.)·2014
    Same author

    Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia.

    Clinical genetics·2014
    Same author

    Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome.

    American journal of medical genetics. Part A·2005
    Same author

    Congenital diaphragmatic hernia and chromosome 15q26: determination of a candidate region by use of fluorescent in situ hybridization and array-based comparative genomic hybridization.

    American journal of human genetics·2005
    Same author

    Mullerian inhibiting substance suppresses tumor growth in the C3(1)T antigen transgenic mouse mammary carcinoma model.

    Proceedings of the National Academy of Sciences of the United States of America·2005
    Same journal

    Reimagining the Surgical Safety Checklist Through a Pediatric Lens.

    Journal of pediatric surgery·2026
    Same journal

    Bridge Fixation Provides Consistent Implant Stability Across Surgical Techniques: A Multicenter Study.

    Journal of pediatric surgery·2026
    Same journal

    National Benchmarks for Penetrating Head Injury in U.S. Children and Adolescents: Mechanism, Intent, and Disparities in Mortality.

    Journal of pediatric surgery·2026
    Same journal

    Long-Term Growth and Neurodevelopmental Outcomes of a Standardized Gastroschisis Feeding Protocol: a retrospective cohort study.

    Journal of pediatric surgery·2026
    Same journal

    Economic Evaluation of Hirschsprung Disease Testing Strategies for Children with Medically-Refractory Chronic Constipation: A Cost-Effectiveness Analysis.

    Journal of pediatric surgery·2026
    Same journal

    Preoperative underweight is associated with a more complicated perioperative course and impairs recovery in Hirschsprung's disease: The pivotal role of weight-for-age z-score.

    Journal of pediatric surgery·2026
    See all related articles

    Immunosuppressive drugs like cyclosporine and dexamethasone do not prevent liver regeneration after partial hepatectomy in rats, despite causing weight loss. This supports further research into liver segment transplantation in immunosuppressed recipients.

    Area of Science:

    • Hepatology
    • Immunology
    • Regenerative Medicine

    Background:

    • Liver segment transplantation is a potential therapeutic strategy.
    • Understanding liver regeneration under immunosuppression is crucial for its feasibility.

    Purpose of the Study:

    • To investigate the effects of immunosuppressive agents on liver regeneration following partial hepatectomy in rats.
    • To assess the impact of cyclosporine and dexamethasone, alone and in combination, on liver DNA synthesis and mass accretion.

    Main Methods:

    • Partial hepatectomy was performed on adult male rats.
    • Rats were treated with cyclosporine, dexamethasone, a combination, or vehicle.
    • Body weight, liver weight, and liver DNA content were monitored over time.

    Related Experiment Videos

    Main Results:

    • All immunosuppressed groups exhibited weight loss, most pronounced with combined treatment.
    • Cyclosporine alone promoted significant liver DNA increase (4-fold) within 6 days.
    • Dexamethasone and combination treatment led to a 2.5-fold increase in liver DNA, reaching 80% of original levels, though the combination group showed a decline after day 6.

    Conclusions:

    • Cyclosporine and dexamethasone do not inhibit DNA synthesis or new liver mass accretion post-hepatectomy, despite adverse effects on weight.
    • These findings encourage further investigation into liver segment transplantation in immunosuppressed hosts.